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The relationship between family history of breast, ovarian and endometrial cancer and risk of breast cancer was
analysed using data from a case-control study of breast cancer conducted in the greater Milan area. Northern Italy. The
cases studied were 3415 women (median age 52 years, range 23-74) who had histologically confirmed breast cancer
diagnosed within the year preceding the interview. The controls were 2916 women (median age 54 years; range 21-74)
in hospital for a spectrum of acute illnesses excluding gynaecological, hormonal or neoplastic conditions. A total of 375
cases (11.0%) and 128 controls (4.4%) reported a history of breast cancer in first degree relatives. Compared with
women with no family history of breast cancer, the RR was 2.7 (95% confidence interval ICI] : 2.2-3.3) in those with
one first degree relative affected and 2.8 (95% Cl : 1.3-5.7) in those with two or more affected relatives. In comparison
with women without family history of ovarian cancer the RR of breast cancer was 1.4 (95% Cl : 0.9-2.3) for those
reporting one or more first degree relatives with ovarian cancer. However, the multivariate estimate for family history of
ovarian cancer, including a term for familial breast cancer, decreased to 0.8 (95% Cl : 0.5-1.4). The risk of breast
cancer was similar in women reporting a family history of breast cancer (RR = 2.2) and in those reporting a family
history of both breast and ovarian cancer (RR = 2.5), in comparison with women reporting no family history of breast
and/or ovarian cancer. When the relation with family history of breast cancer was analysed in strata of women with
and without family history of ovarian cancer, no difference was found in the RR estimates: the RR for family history of
breast cancer was 2.8 in women with family history of ovarian cancer and 2.7 in those without history of ovarian
cancer. No relation was found between history of endometrial cancer in first degree relatives and risk of breast cancer.
There is consistent evidence that a family history of
breast cancer is associated with 2-3-fold increased risk
of the disease.1"4 Less well-defined is the relationship
between breast cancer risk and family history of other
female hormone-related cancers. An increased risk of
breast cancer of about 50% was reported in women
with a family history of ovarian cancer in the Cancer
and Steroid Hormone (CASH) Study, a large popu-
lation-based case-control study conducted in eight
areas of the US,5 but other data are scanty and not
always consistent.6"8 With regard to family history of
endometrial cancer, a positive association was again
observed in the CASH5 study, which systematically
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examined the familial incidence and distribution of
malignancies among relatives of breast cancer patients,
and in another study conducted in the USA.9
To analyse the issue further, we considered the risk
of breast cancer in women with a family history of
breast, ovarian and endometrial cancer using data
from a large case-control study of breast cancer con-
ducted in Northern Italy.
SUBJECTS AND METHODS
The data were derived from an ongoing case-control
study of breast cancer conducted in the greater Milan
area, northern Italy, whose general design has already
been described.10'" Trained interviewers identified
and questioned women admitted to a network of
hospitals for breast cancer and a wide spectrum of
other conditions.
The cases studied were women < 75 years who had
histologically confirmed breast cancer diagnosed
within the year preceding the interview and had been
admitted to the National Cancer Institute of Milan,
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several general and university hospitals and the
Ospedale Maggiore (which includes the four largest
teaching and general hospitals in Milan). A total of
3415 subjects (median age 52 years; range 23-74 years)
were interviewed.
The controls were women residing in the same area
who had been admitted for acute conditions to several
specialized university clinics and to the Ospedale
Maggiore of Milan for diseases other than malignant,
hormonal, or gynaecological conditions. A total of
2916 controls (median age 54 years; range 21-74 years)
were included. Of these, 29% were admitted for
traumatic conditions (mostly fractures and sprains),
26% had non-traumatic orthopaedic disorders (mostly
low back pain and disc disorders), 16% were admitted
for acute surgical conditions (mostly abdominal, such
as acute appendicitis or strangulated hernia), and 30%
had other illnesses, e.g. ear, nose and throat or dental
disorders.
A standard questionnaire was used to obtain data on
personal characteristics and habits, reproductive and
menstrual history and related medical and drug use
history. Information was also collected on the number
of sisters, and on breast, ovarian and endometrial
cancer in first degree relatives (mother and sisters).
The interviewers inspected clinical records whenever
available for confirmation of data on family history.
No information was collected on the ages of onset of
tumours in relatives. Less than 3% of the eligible
subjects (cases and controls) refused the interview.
The present report is based on data collected before
October 1991.
Data Analysis
We computed the relative risks (RR) of breast cancer
according to family history of breast, ovarian and
endometrial cancer, together with their 95% con-
fidence intervals (CI). To allow simultaneously for the
effect of the number of sisters and other potentially
confounding factors, we used unconditional logistic
regression, with maximum likelihood fitting.12 Included
in the regression equations were terms for age, years of
education, age at first birth, age at menarche and at
menopause, number of sisters and family history of
breast, ovarian and endometrial cancer.
RESULTS
The distribution of cases and controls according to
age, education, reproductive and menstrual history
and number of sisters is shown in Table 1. As ex-
pected, cases tended to be more educated, to report
later age at first birth and at menopause and earlier
menarche than controls.
TABLE I Distribution of 3415" breast cancer cases and 2916 controls
according to selected variables. Milan, Italy 1983-1991
Age (years)
<35
35-44
45-54
55-64
65-74
Education (years)
<7
7-11
£12
Parity
Nulliparae
Parae
Age at first birth
<25
25-29
>30
Age at menarche (years)
<15
>15
Age at menopause (years)
Premenopause
<45
45^*9
>50
Number of sisters
0
1
>2
Breast cancer
No.
139
656
1036
951
633
1727
957
731
640
2775
1090
1100
585
2940
475
1425
351
575
1058
945
1091
1379
(4)
(19)
(30)
(28)
(19)
(51)
(28)
(21)
(19)
(81)
(39)
(40)
(21)
(86)
(14)
(42)
(10)
(17)
(31)
(28)
(32)
(40)
Controls
No.
245
492
790
812
577
1688
727
501
624
2292
1123
795
374
2422
494
1087
413
569
843
733
866
1317
Ck)
(8)
(17)
(27)
(28)
(20)
(58)
(25)
(17)
(21)
(79)
(50)
(35)
(16)
(83)
(17)
(37)
(14)
(20)
(29)
(25)
(30)
(45)
* In some cases the sum of strata does not add up to the total because
of missing values.
The relation between history of breast, ovarian and
endometrial cancer in first degTee relatives and risk of
breast cancer is considered in Table 2.
Compared with women with no family history of
breast cancer, the RR for the disease was 2.7 in those
with one first degree relative and 2.8 in those with two
relatives affected. An increased risk of breast cancer
emerged in women with a family history of ovarian
cancer, too: in comparison with women with no such
history, the RR for breast cancer was 1.4 (95% CI :
0.9-2.3) for those reporting one or more first degree
relatives with ovarian cancer. No relation was found
between history of endometrial cancer in first degree
relatives and risk of breast cancer. Multivariate
estimates were consistent with the age-adjusted ones
for breast and endometrial cancer history in first
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degree relatives, but the multivariate estimate for
family history of ovarian cancer, including the term
for familial breast cancer, decreased to 0.8 (95% CI :
0.5-1.4). In fact, when the data were stratified for
family breast cancer, a family history of ovarian
cancer did not increase the risk of breast cancer either
in women with a family history of breast cancer or in
those without.
The risk of breast cancer was similar in women who
reported a family history of breast cancer and in those
who reported a family history of both breast and
ovarian cancer, the RR estimates being respectively
2.7 and 2.5 in comparison with women reporting no
family history of breast and/or ovarian cancer
(Table 3). No association was observed for women
with history of ovarian cancer only (RR = 0.9).
We analysed further the relation between family
history of breast cancer and the risk of breast cancer
according to age at diagnosis of breast cancer, affected
relative (mother or sister) and the presence of ovarian
TABLE 2 Distribution of 3415° breast cancer cases and 2916 controls, and corresponding relative risks according to history of breast, ovanan and
endometrial cancer in first degree relatives. Milan Italy 1983-1991
Family history
of
Breast cancer Dntrols
2786
119
9
2885
30
2808
106
RR (95% CI)b
Age-adjusted
|d
2.7 (2.2-3.3)
2.8 (1.3-5.7)
ld
1.4 (0.9-2.3)
ld
1.2 1(0.9-1.5)
MRLC
2.7 (2.2-3.4)
2.8 (1.3-5.9)
ld
0.8 (0.5-1.4)
ld
1.1 (0.8-1.4)
Breast cancer
No
1 relative affected
> 2 relatives affected
Ovarian cancer
No
Yes
Endometrial cancer
No
Yes
3033
348
27
3361
50
3261
147
• In some cases, the sum of strata does not add up to the total because of missing values.
b
 RR = relative risk. CI = confidence interval.
c
 Estimates from multiple logistic regression equations including terms for age, education, age at first birth, age at menarche and menopause,
number of sisters and the above listed variables.
d
 Reference category.
TABLE 3 Distribution of 3415° breast cancer cases and 2916 controls according to history of breast and ovarian cancer or both in first degree
relatives and corresponding relative risks. Milan, Italy 1983-1991
Breast cancer Controls RR (95% Cl)b
Age-adjusted MRLC
No family history of breast
and/or ovarian cancer
Family history of
breast cancer only
ovarian cancer only
breast and ovarian cancer
3016
342
17
33
2768
116
18
12
2.7 (2.2-3.3)
0.9 (0.4-1.7)
2.5 (1.3^.8)
2.7 (2.2-3.4)
0.8 (0.4-1.6)
2.6 (1.3-5.0)
* In some cases, the sum of strata does not add up to the total because of missing values.
b
 RR = relative risk. CI = confidence interval.
c
 Estimates from multiple logistic regression equations including terms for age, education, age at first birth, age at menarche and menopause, and
number of sisters.
d
 Reference category.
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TABLE 4 Relative risk (and 95% Cl) of breast cancer in women with
history of breast cancer in first degree relatives in strata of age at
diagnosis, affected relative and family history of ovarian cancer.
Milan, Italy 1983-1991
Age at breast cancer
diagnosis (years)
Affected relative
Family history of
ovarian cancer
Stratum
<45
>45
Mother
Sister
No
Yes
(68)b
(307)
(219)
(172)
(342)
(33)
Relative risk*
(95% Cl)
2.5 (1.6-4.0)
2.7 (2.1-3.3)
2.8 (2.1-3.7)
2.1 (1.6-2.8)
2.7 (2.2-3.3)
2.8 (1.9-4.1)
* Reference category 'No family history of breast cancer'. Estimates
from multiple logistic regression equations including terms for educa-
tion, age at first birth, age at menarche and at menopause, number of
sisters and the above variables.
b
 Number of breast cancer cases are given in parenthesis.
cancer in the family (Table 4). No consistent difference
was found in the RR estimates among different strata
of these covariates.
DISCUSSION
The results of this study offer further evidence that a
family history of breast cancer is an indicator of risk of
the disease.1"4 A family history of ovarian cancer was
apparently associated with the risk of breast cancer in
the unadjusted analysis, but this finding disappeared
when analysis took into account a family history of
breast cancer. No association emerged with a family
history of endometrial cancer.
Recall bias is probably the major potential bias in
case-control studies on family history of diseases.
Cases with breast cancer might be more aware of their
family cancer history (particularly female cancers)
than controls. However, in our study only first degree
relatives were considered and the relationship between
breast cancer and family history of the disease was
consistent among different strata of age and socio-
economic status; in particular it was confirmed in
younger women and upper social classes. Further-
more, no relation emerged with another female
tumour such as endometrial cancer. With regard to
selection bias, cases and controls were drawn from
comparable catchment areas and participation was
almost complete.
Several studies have shown an increased risk of
breast cancer in women with a history of the disease in
their relatives,1^ the estimated RRs tending to be
systematically higher at younger ages.1314
Less clear is the relation between breast cancer
risk and history of ovarian and endometrial cancer.
Indirect support to the suggestion of an association
between breast and ovarian cancer derives from the
observation in some families of cases of ovarian and
breast cancer (breast-ovarian cancer syndrome),15'16
which, however, could not provide quantitative in-
formation on the impact of this syndrome at a popula-
tion level. Further, there are epidemiological data
showing an increased risk of ovarian cancer in women
with a family history of breast cancer.17-18 An in-
creased risk of breast cancer in women with family
history of ovarian cancer was reported in a recent
analysis of the CASH study.5 In that study, in women
aged 45-54 years a first degree relative with ovarian
cancer was associated with a twofold risk, an increase
equivalent to that for a first degree relative with breast
cancer. However, in the CASH analyis the potential
confounding effect of a family history of breast cancer
was not taken into account in evaluating the role of
ovarian cancer history in relatives on the risk of breast
cancer.
In this study, women with a family history of
breast cancer more often reported a family history of
ovarian cancer than those with no history of breast
cancer, thus giving some apparent support to the sug-
gested breast-ovarian cancer syndrome. However, the
simultaneous presence of both diseases in relatives did
not increase the risk of breast cancer, and hence the
determinant of risk appeared to be a family history of
breast cancer.
No association emerged between breast cancer risk
and history of endometrial cancer in first degree
relatives. This is in agreement with the findings from
the CASH study.5 Furthermore, no relation emerged
in a population-based study of endometrial cancer on
young women conducted in California,19 and in other
studies which have analysed the risk of endometrial
cancer in women with a family history of breast
tumours.20'21
In conclusion, in this study it appears that genetic—
or familial—factors as measured by the collection of
family histories, are probably not a common deter-
minant of breast cancer risk on a population level.
There was a significant association between family
history of breast cancer and breast cancer risk, but this
association was limited on a population level (account-
ing for <5% of breast cancer cases.22) Family history
of endometrial cancer was not an important deter-
minant of subsequent breast cancer risk, and also an
apparent association with ovarian cancer was largely
or totally explained by the simultaneous history of
breast and ovarian cancer in the same family.
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